The Selling of ADHD: Diagnoses, Prescriptions Soar After 20-Year Marketing Effort by Big Pharma

PILL MAN

(FEDERALJACK)   Taken at face value, the latest figures on Attention Deficit Hyperactivity Disorder (ADHD) suggest a growing epidemic in the United States. According to the Centers for Disease Control, 15 percent of high school children are diagnosed with ADHD. The number of those on stimulant medication is at 3.5 million, up from 600,000 two decades ago. ADHD is now the second most common long-term diagnosis in children, narrowly trailing asthma. But a new report in the New York Times questions whether these staggering figures reflect a medical reality, or an over-medicated craze that has earned billions in profits for the pharmaceutical companies involved.

Sales for ADHD drugs like Adderall and Concerta topped $9 billion in the United States last year, a more than 500 percent jump from a decade before. The radical spike in diagnoses has coincided with a 20-year marketing effort to promote stimulant prescriptions for children struggling in school, as well as for adults seeking to take control of their lives. The marketing effort has relied on studies and testimonials from a select group of doctors who have received massive speaking fees and funding grants from major pharmaceutical companies.

PT1

PT2

One Response to The Selling of ADHD: Diagnoses, Prescriptions Soar After 20-Year Marketing Effort by Big Pharma

Leave a Reply

Your email address will not be published. Required fields are marked *

Show some support!

We are 100% Listener & User supported!! Every little bit helps us continue. Donations help fund the site and keep all the free information on it. Thanks in advance and KEEP UP THE FIGHT!!!

News Categories
Col. L Fletcher Prouty: Secret Team
FEDERALJACK'S TWITTER POPEYE'S TWITTER